Evidence map›Paper›PMID 41325059›Full record

ReviewGut microbes2025

Added sugars, gut microbiota, and host health.

Yanbo Zhang, Ryan W Walker, Robert C Kaplan, Qibin Qi

Abstract readReview
In one paragraph

Review in Gut microbes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yanbo ZhangDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.ORCID 0000-0003-1054-9657
Ryan W WalkerDepartment of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Robert C KaplanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Qibin QiDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.

Funding

The Mount Sinai Transdisciplinary Center on Early Environmental ExposuresP30ES023515 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Maria Jose Rosa · 2014 to 2026
$21.3M
Human Gut Microbiome and Incident Diabetes Risk in U.S. PopulationsR01DK126698 · NIDDK · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI QI, QIBIN, SUN, QI · 2021 to 2024
$2.5M
Metabolomics signatures underlying diet, lifestyle and gut microbiota for diabetesR01DK119268 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI QI, QIBIN · 2019 to 2022
$2.4M
The effects of a high fructose diet on the gut microbiome and metabolic health: A controlled clinical intervention studyR01DK137968 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ryan Walker · 2024 to 2026
$2.1M
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adultsR01DK134672 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI BURK, ROBERT D, KAPLAN, ROBERT C · 2023 to 2025
$2.1M
Microbiome and AD/ADRD Risk in SOLR01AG085320 · NIA · UNIVERSITY OF MASSACHUSETTS LOWELL · PI Robert C Kaplan, Natalia Palacios · 2025 to 2026
$1.6M
NIA NIH HHS R01 AG085320NIDDK NIH HHS R01 DK119268NIDDK NIH HHS R01 DK126698NIDDK NIH HHS R01 DK134672NIDDK NIH HHS R01 DK137968NIEHS NIH HHS P30 ES023515NIH HHS 75N92023R0192
6 · The paper itself

Abstract

Excessive intake of added sugars is a global public health concern, given its established links with cardiometabolic disease and other chronic conditions. Emerging evidence suggests that the gut microbiota might mediate the harms of high sugar intake. In this review, we summarize evidence from animal and human studies regarding the impact of added sugar intake on gut microbiota diversity and composition, and discuss potential mechanisms linking sugar-induced microbial changes to health outcomes. Added sugars, including glucose, fructose, and sucrose, can alter gut microbial diversity, enrich sugar-utilizing taxa, and deplete short-chain fatty acid-producing bacteria. These microbial changes may impair gut barrier integrity, increase luminal oxygen and alternative electron acceptors under inflammatory conditions, reduce short-chain fatty acid production, alter bile acid and amino acid metabolism, and promote translocation of endotoxin across the gut barrier into the bloodstream. Collectively, these pathways may link added sugar intake to irritable bowel syndrome, obesity, liver steatosis, diabetes, and cardiovascular diseases. However, inconsistent results on alterations in the gut microbiota related to added sugar intake were observed across studies, which may be due to differences in sugar dose and form (liquid vs. solid), as well as population variation in background diet, host genetics, and gut microbial ecology. Future research should focus on mechanistic investigations, characterization of inter-individual variability in response to added sugar intake, and clinical studies to assess whether dietary or therapeutic interventions can reverse sugar-induced gut microbial changes and improve host health outcomes.

Indexed as

Dietary SugarsGastrointestinal MicrobiomeAnimalsBacteriaFatty Acids, VolatileHumansObesityDietary SugarsFatty Acids, VolatileAdded sugaramino acid metabolismcardiometabolic healthgut microbiotainflammationshort-chain fatty acid

Identifiers

PMID41325059
PMCPMC12674407

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.